IntrinsicIntrinsic
← Scroll for more →

Financial Statements — XBIO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents6.477.357.884.124.785.166.176.847.307.828.989.7810.7311.9913.1013.8514.9316.1618.2419.70
Total Current Assets6.657.608.055.075.355.486.597.038.018.389.5911.2612.0412.8713.6514.1715.3816.8918.7220.58
Property, Plant & Equipment----------------------------0.00------0.000.00
Goodwill------------------------------------0.000.00
Total Non-current Assets*0.310.310.310.000.000.310.311.021.021.021.020.700.700.841.071.411.091.091.090.70
Total Assets6.977.918.365.075.355.796.908.059.039.3910.6111.9612.7513.7214.7215.5716.4717.9819.8221.29
Accounts Payable0.320.560.260.580.350.240.280.240.280.210.240.450.220.260.290.200.470.280.360.25
Total Current Liabilities0.890.960.971.110.900.670.891.011.590.720.811.070.870.861.071.051.281.061.421.12
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities0.890.960.971.110.900.670.891.011.590.720.811.070.870.861.071.051.281.061.421.12
Retained Earnings(201.26)(200.33)(199.88)(199.30)(198.79)(198.10)(197.19)(196.14)(195.70)(194.43)(193.23)(192.06)(191.01)(189.96)(189.10)(187.62)(186.81)(184.14)(182.55)(180.71)
Total Stockholder Equity6.076.957.403.964.455.126.017.047.458.689.8010.8911.8812.8613.6514.5215.1916.9218.3920.16
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.660.810.771.030.590.590.650.610.730.510.670.610.650.610.490.410.420.390.330.35
Research & Development0.550.660.770.760.660.881.040.370.930.940.981.020.900.601.190.402.081.101.230.78
Selling, General & Admin1.080.650.620.820.660.660.710.751.130.830.950.740.950.930.860.861.030.910.980.95
Total Operating Expenses1.631.311.391.571.311.541.751.112.061.781.931.761.851.522.051.263.102.012.211.73
Operating Income(0.97)(0.50)(0.62)(0.54)(0.72)(0.94)(1.10)(0.50)(1.34)(1.27)(1.26)(1.15)(1.20)(0.92)(1.56)(0.85)(2.69)(1.62)(1.87)(1.38)
Pretax Income--------------------------------------(1.35)
Tax Provision0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Net Income(0.93)(0.46)(0.58)(0.51)(0.69)(0.90)(1.05)(0.44)(1.27)(1.20)(1.17)(1.06)(1.05)(0.86)(1.48)(0.80)(2.67)(1.59)(1.84)(1.35)
Basic EPS(0.41)(0.20)(0.21)(0.33)(0.45)(0.59)(0.68)(0.28)(0.83)(0.78)(1.27)(0.69)(0.69)(0.06)(0.10)(0.06)(0.19)------
Diluted EPS(0.41)(0.20)(0.21)(0.33)(0.45)(0.59)(0.68)(0.28)(0.83)(0.78)(1.27)(0.69)(0.69)(0.06)(0.10)(0.06)(0.19)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(0.88)(0.54)(0.24)(0.66)(0.38)(1.00)(0.67)(0.46)(0.53)(1.16)(0.79)(0.95)(1.27)(1.10)(0.75)(1.08)(0.73)(2.09)(1.46)(1.03)
Investing Cash Flow--------------------0.000.000.00--0.000.00(0.50)------
Financing Cash Flow----------------------------0.000.00----0.0011.45
← Scroll for more columns →